Alberta Investment Management Corp Has $4.17 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Alberta Investment Management Corp raised its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 526.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,700 shares of the company's stock after purchasing an additional 21,600 shares during the quarter. Alberta Investment Management Corp's holdings in Clorox were worth $4,174,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CLX. Mizuho Securities USA LLC lifted its holdings in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the period. Ilex Capital Partners UK LLP raised its position in shares of Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock worth $88,315,000 after purchasing an additional 453,624 shares during the period. International Assets Investment Management LLC lifted its holdings in shares of Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company's stock valued at $877,390,000 after purchasing an additional 435,971 shares during the last quarter. Boston Trust Walden Corp boosted its position in shares of Clorox by 5,442.5% in the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company's stock valued at $44,622,000 after purchasing an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. raised its holdings in Clorox by 302.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock worth $57,390,000 after buying an additional 265,455 shares during the period. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

CLX traded up $4.34 during trading on Friday, hitting $157.41. The company's stock had a trading volume of 2,375,494 shares, compared to its average volume of 1,353,779. The firm's 50 day moving average price is $157.87 and its two-hundred day moving average price is $159.63. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a market capitalization of $19.39 billion, a price-to-earnings ratio of 43.01, a price-to-earnings-growth ratio of 2.58 and a beta of 0.42. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the firm posted $2.16 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CLX has been the subject of a number of recent analyst reports. Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Finally, Wells Fargo & Company raised their price target on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $158.21.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.